+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Artificial Organ And Bionics Market Size, Share & Industry Trends Analysis Report By Product (Artificial Organs and Artificial Bionics), By Technology (Mechanical and Electronic), By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 95 Pages
  • June 2022
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5636400
The Asia Pacific Artificial Organ And Bionics Market is expected to witness market growth of 11.0% CAGR during the forecast period (2022-2028).

Generally, bionic limbs function by sensing impulses sent by the patient's muscles. For instance, sensors is expected to respond to elicit the proper movement when a person equips their bionic limb or flexes the muscles below or above the limb. Sensors are frequently used in bionic limbs in order to identify these muscle movements. The sensors in the bionic arm receive a signal to flex or move the limb. The majority of bionic limbs have processors within that can recognize muscle impulses. Implanting sensors into the residual muscles of the limb stump is necessary for some bionic limbs.

This kind of bionic limb is significantly more sophisticated and enables users to mentally manipulate the limb. Many bionic limbs are plug and play, indicating that they are simple to put on and take off and only utilized when necessary. Although many bionic limbs are custom-built to the users' muscles' specifications, bionic limbs do not require surgery to function. Users have complete control over this kind of prosthetic limb, which may adjust to how rapidly or slowly the muscles contract. The bionic limb can react more slowly when the muscles are lightly tight while it is expected to react more swiftly when muscles are tightened quickly.

In regional countries, there is a number of fatalities caused by road accidents. According to the National Crime Records Bureau, the number of road accidents in India was recorded at 3,68,828 in 2020. Also, the mortality rate of people involved in these accidents remained at 0.45 in 2020. In addition, the number of people killed in traffic accidents is huge. 1,46,354 people died and 3,36,248 people were injured as a result of these road incidents in 2020. Maximum fatalities in traffic accidents were reported in the states of Uttar Pradesh (21,156 fatalities), Maharashtra (13,940 fatalities), and Madhya Pradesh (12,629 fatalities). These three states accounted for 14.5%, 9.5%, and 8.6% of all traffic fatalities, respectively, and collectively for 32.6% (47,725 out of 1,46,354) of all fatalities reported at the all-India level during 2020.

A few of these accidents caused major injuries to people. In many cases, the limbs of people were also damaged in a way that they were not able to function. However, due to the introduction of artificial bionics, the life quality of these people is becoming majorly enhanced. This factor is majorly increasing the demand for artificial limbs across the region. Hence, the growth of the regional artificial organ and bionics market is being propelled.

The China market dominated the Asia Pacific Artificial Organ And Bionics Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $2,539.2 million by 2028. The Japan market is poised to grow at a CAGR of 10.4% during (2022-2028). Additionally, The India market is expected to display a CAGR of 11.7% during (2022-2028).

Based on Product, the market is segmented into Artificial Organs (Kidney, Heart, Lungs, Liver, and Pancreas) and Artificial Bionics (Cochlear Implant, Bionic limbs, Exoskeleton, Vision bionics, and Brain bionics). Based on Technology, the market is segmented into Mechanical and Electronic. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abiomed, Inc., Berlin Heart GmbH, Zimmer Biomet Holdings, Inc., Boston Scientific Corporation, Cochlear Ltd., Ekso Bionics Holdings, Inc., Jarvik Heart, Inc., Medtronic PLC, iWALKFree, Inc., and Edwards Lifesciences Corporation.

Scope of the Study


Market Segments Covered in the Report:


By Product
  • Artificial Organs
  • Kidney
  • Heart
  • Lungs
  • Liver
  • Pancreas
  • Artificial Bionics
  • Cochlear Implant
  • Bionic limbs
  • Exoskeleton
  • Vision bionics
  • Brain bionics
By Technology
  • Mechanical
  • Electronic
By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players


List of Companies Profiled in the Report:

  • Abiomed, Inc.
  • Berlin Heart GmbH
  • Zimmer Biomet Holdings, Inc.
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • Ekso Bionics Holdings, Inc.
  • Jarvik Heart, Inc.
  • Medtronic PLC
  • iWALKFree, Inc.
  • Edwards Lifesciences Corporation

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Artificial Organ And Bionics Market, by Product
1.4.2 Asia Pacific Artificial Organ And Bionics Market, by Technology
1.4.3 Asia Pacific Artificial Organ And Bionics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Artificial Organ And Bionics Market by Product
3.1 Asia Pacific Artificial Organs Market by Country
3.2 Asia Pacific Artificial Organ And Bionics Market by Artificial Organs Type
3.2.1 Asia Pacific Kidney Market by Country
3.2.2 Asia Pacific Heart Market by Country
3.2.3 Asia Pacific Lungs Market by Country
3.2.4 Asia Pacific Liver Market by Country
3.2.5 Asia Pacific Pancreas Market by Country
3.3 Asia Pacific Artificial Bionics Market by Country
3.4 Asia Pacific Artificial Organ And Bionics Market by Artificial Bionics Type
3.4.1 Asia Pacific Cochlear Implant Market by Country
3.4.2 Asia Pacific Bionic limbs Market by Country
3.4.3 Asia Pacific Exoskeleton Market by Country
3.4.4 Asia Pacific Vision bionics Market by Country
3.4.5 Asia Pacific Brain bionics Market by Country
Chapter 4. Asia Pacific Artificial Organ And Bionics Market by Technology
4.1 Asia Pacific Mechanical Market by Country
4.2 Asia Pacific Electronic Market by Country
Chapter 5. Asia Pacific Artificial Organ And Bionics Market by Country
5.1 China Artificial Organ And Bionics Market
5.1.1 China Artificial Organ And Bionics Market by Product
5.1.1.1 China Artificial Organ And Bionics Market by Artificial Organs Type
5.1.1.2 China Artificial Organ And Bionics Market by Artificial Bionics Type
5.1.2 China Artificial Organ And Bionics Market by Technology
5.2 Japan Artificial Organ And Bionics Market
5.2.1 Japan Artificial Organ And Bionics Market by Product
5.2.1.1 Japan Artificial Organ And Bionics Market by Artificial Organs Type
5.2.1.2 Japan Artificial Organ And Bionics Market by Artificial Bionics Type
5.2.2 Japan Artificial Organ And Bionics Market by Technology
5.3 India Artificial Organ And Bionics Market
5.3.1 India Artificial Organ And Bionics Market by Product
5.3.1.1 India Artificial Organ And Bionics Market by Artificial Organs Type
5.3.1.2 India Artificial Organ And Bionics Market by Artificial Bionics Type
5.3.2 India Artificial Organ And Bionics Market by Technology
5.4 South Korea Artificial Organ And Bionics Market
5.4.1 South Korea Artificial Organ And Bionics Market by Product
5.4.1.1 South Korea Artificial Organ And Bionics Market by Artificial Organs Type
5.4.1.2 South Korea Artificial Organ And Bionics Market by Artificial Bionics Type
5.4.2 South Korea Artificial Organ And Bionics Market by Technology
5.5 Singapore Artificial Organ And Bionics Market
5.5.1 Singapore Artificial Organ And Bionics Market by Product
5.5.1.1 Singapore Artificial Organ And Bionics Market by Artificial Organs Type
5.5.1.2 Singapore Artificial Organ And Bionics Market by Artificial Bionics Type
5.5.2 Singapore Artificial Organ And Bionics Market by Technology
5.6 Malaysia Artificial Organ And Bionics Market
5.6.1 Malaysia Artificial Organ And Bionics Market by Product
5.6.1.1 Malaysia Artificial Organ And Bionics Market by Artificial Organs Type
5.6.1.2 Malaysia Artificial Organ And Bionics Market by Artificial Bionics Type
5.6.2 Malaysia Artificial Organ And Bionics Market by Technology
5.7 Rest of Asia Pacific Artificial Organ And Bionics Market
5.7.1 Rest of Asia Pacific Artificial Organ And Bionics Market by Product
5.7.1.1 Rest of Asia Pacific Artificial Organ And Bionics Market by Artificial Organs Type
5.7.1.2 Rest of Asia Pacific Artificial Organ And Bionics Market by Artificial Bionics Type
5.7.2 Rest of Asia Pacific Artificial Organ And Bionics Market by Technology
Chapter 6. Company Profiles
6.1 Medtronic PLC
6.1.1 Company overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expenses
6.2 Boston Scientific Corporation
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 SWOT Analysis
6.3 Abiomed, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional Analysis
6.3.4 Research & Development Expenses
6.4 Berlin Heart GmbH
6.4.1 Company Overview
6.5 Jarvik Heart, Inc.
6.5.1 Company Overview
6.6 Zimmer Biomet Holdings, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Cochlear Ltd.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expense
6.8 Ekso Bionics Holdings, Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expenses
6.9 iWALKFree, Inc.
6.9.1 Company Overview
6.10. Edwards Lifesciences Corporation
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Regional Analysis
6.10.4 Research & Development Expenses

Companies Mentioned

  • Abiomed, Inc.
  • Berlin Heart GmbH
  • Zimmer Biomet Holdings, Inc.
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • Ekso Bionics Holdings, Inc.
  • Jarvik Heart, Inc.
  • Medtronic PLC
  • iWALKFree, Inc.
  • Edwards Lifesciences Corporation

Methodology

Loading
LOADING...